The U.S. wound debridement market size was valued at USD 1.53 billion in 2024 and is projected to reach USD 2.26 billion by 2033, growing at a CAGR of 4.3% from 2025 to 2033. The increasing prevalence of diabetes, obesity, and the growing number of traumatic injuries and chronic wounds continue to drive demand for advanced wound debridement solutions.
According to the CDC, approximately 129 million Americans live with at least one major chronic illness, and nearly 2% of the population suffers from chronic wounds, with incidence rising notably among older adults. These wounds, such as diabetic foot ulcers, pressure sores, and venous stasis ulcers, present significant clinical challenges and are associated with extended healing times, increased risk of complications, and substantial healthcare resource consumption.
On the regulatory and innovation front, U.S. federal agencies like the FDA are actively reshaping the landscape. The FDA has proposed reclassifying certain wound-care products-gels, creams, ointments, and liquid washes containing antimicrobials-into Class II or III devices, requiring more rigorous oversight through 510(k) notifications or premarket approvals (PMAs).
This product will be delivered within 2 business days.
According to the CDC, approximately 129 million Americans live with at least one major chronic illness, and nearly 2% of the population suffers from chronic wounds, with incidence rising notably among older adults. These wounds, such as diabetic foot ulcers, pressure sores, and venous stasis ulcers, present significant clinical challenges and are associated with extended healing times, increased risk of complications, and substantial healthcare resource consumption.
On the regulatory and innovation front, U.S. federal agencies like the FDA are actively reshaping the landscape. The FDA has proposed reclassifying certain wound-care products-gels, creams, ointments, and liquid washes containing antimicrobials-into Class II or III devices, requiring more rigorous oversight through 510(k) notifications or premarket approvals (PMAs).
U.S. Wound Debridement Market Report Segmentation
This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. wound debridement market report based on product, method, wound type, mode of purchase, and end use:Product Outlook (Revenue, USD Million, 2021 - 2033)
- Gels
- Ointments & Creams
- Surgical Devices
- Medical Gauzes
- Ultrasonic Devices
- Others
Method/Procedure Outlook (Revenue, USD Million, 2021 - 2033)
- Autolytic
- Enzymatic
- Surgical
- Mechanical
- Others
Wound Type Outlook (Revenue, USD Million, 2021 - 2033)
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Burn Wound
- Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Homecare
- Others
Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
- Prescription
- Over The Counter
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Wound Debridement Market Variable Trends & Scope
Chapter 4. U.S. Wound Debridement Market: Product Estimates & Trend Analysis
Chapter 5. U.S. Wound Debridement Market: Method/Procedures Estimates & Trend Analysis
Chapter 6. U.S. Wound Debridement Market: Wound Type Estimates & Trend Analysis
Chapter 7. U.S. Wound Debridement Market: By End Use Estimates & Trend Analysis
Chapter 8. U.S. Wound Debridement Market: By Mode of Purchase Estimates & Trend Analysis
Chapter 9. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Zimmer Biomet
- Smith+Nephew
- Coloplast Group
- Convatec Group PLC
- C. R. Bard
- Lohmann & Rauscher